Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: A micro-costing study

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Shi, Ju Fang ^a,b,c   Chen, Jun Feng ^d   Canfell, Karen ^b,c   Feng, Xiang Xian ^e   Ma, Jun Fei ^f   Zhang, Yong Zhen ^g   Zhao, Fang Hui ^a   Li, Rong ^a,d   Ma, Li ^d   Li, Zhi Fang ^e   Lew, Jie Bin ^b   Ning, Yan ^d   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b CANCER RESEARCH DIVISION   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d DALIAN MEDICAL UNIVERSITY   (China)

^e CHANGZHI MEDICAL COLLEGE   (China)

^f Xiangyuan Women and Children Hospital   (China)

^g SHANXI CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINA; COST; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MIDDLE AGED; QUALITATIVE RESEARCH; RURAL HEALTH CARE; UTERINE CERVIX TUMOR;

ADULT; CHINA; COSTS AND COST ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; QUALITATIVE RESEARCH; RURAL HEALTH SERVICES; UTERINE CERVICAL NEOPLASMS;

EID: 84861337688     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-123     Document Type: Article

References (22)

1. The burden of cervical cancer in China: synthesis of the evidence. Shi JF, Canfell K, Lew JB, Qiao YL, Int J Cancer 2012 130 641 652 10.1002/ijc.26042 21387308
2. Women's health in rural China. Editorial, Lancet 2009 374 358 19647593
3. Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China. Levin CE, Sellors J, Shi JF, Ma L, Qiao YL, Ortendahl J, O'Shea MK, Goldie SJ, Int J Cancer 2010 127 1404 1411 10.1002/ijc.25150 20049838
4. Prevention of cervical cancer in rural China: Evaluation of HPV vaccination and primary HPV screening strategies. Canfell K, Shi JF, Lew JB, Walker RE, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL, Vaccine 2011 29 2487 2494 10.1016/j.vaccine.2010.12.085 21211586
5. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. Shi JF, Canfell K, Lew JB, Zhao FH, Legood R, Ning Y, Simonella L, Ma L, Kang YJ, Zhang YZ, Smith MA, Chen JF, Feng XX, Qiao YL, BMC Cancer 2011 11 239 10.1186/1471-2407-11-239 21668946
6. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, Methods for the Economic Evaluation of Health Care Programmes Oxford University Press, New York 2005
7. Cost-effectiveness of cervical-cancer screening in five developing countries. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, Wright TC, N Engl J Med 2005 353 2158 2168 10.1056/NEJMsa044278 16291985
8. Mathematical models of cervical cancer prevention in the Asia Pacific region. Goldie SJ, Diaz M, Kim SY, Levin CE, Van MH, Kim JJ, Vaccine 2008 26 Suppl 12 17 M29 18945411
9. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD, J Natl Cancer Inst 2002 94 1469 1483 10.1093/jnci/94.19.1469 12359856
10. Estimating the cost of cervical cancer screening in five developing countries. Goldhaber-Fiebert JD, Goldie SJ, Cost Eff Resour Alloc 2006 4 13 10.1186/1478-7547-4-13 16887041
11. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. Legood R, Gray AM, Mahe C, Wolstenholme J, Jayant K, Nene BM, Shastri SS, Malvi SG, Muwonge R, Budukh AM, Sankaranarayanan, Int J Cancer 2005 117 981 987 10.1002/ijc.21220 16003735
12. Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. Quentin W, Adu-Sarkodie Y, Terris-Prestholt F, Legood R, Opoku BK, Mayaud P, Trop Med Int Health 2011 16 379 89 10.1111/j.1365-3156.2010.02722.x 21214692
13. Operative approaches, indications, and medical economics evaluation of 4180 cases of hysterectomy. Tan XJ, Lang JH, Shen K, Liu ZF, Sun DW, Leng JH, Zhu L, Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003 25 406 409 12974083
14. Cost-benefit of expanding cervical cancer screening. Deng J, Tan H, Yang T, Huang X, Zhou S, Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010 35 470 475 20543471
15. Hospitalization expenses for patients with cervical cancer and its influential factors. Guan XH, Lu ZX, Hu CP, Liu XM, Chinese Health Service Management 2004 20 104 105
16. Trend of hospital fee of breast and cervical cancer. Wang MZ, Hu XB, Zheng S, Zhang RQ, Lu YJ, Kou JN, Li XF, Yang LP, Shi LL, Bai YN, Chin J Public Health 2009 25 1183 1184
17. Cancer Foundation of China: Introduction of the Demonstration Project and Cancer Early Detection and Treatment Project. 2011 [http://www.chinacancernet. org.cn/Info/SortContentEn.asp?ID=26]
18. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT, Lancet Oncol Bureau of Statistics of Shanxi Province: Statistical Information of Shanxi. 2011 [http://www.stats-sx.gov.cn]
19. Statistical communique of Shanxi Province on the 2008 civil economic and social development. Bureau of Statistics of Shanxi Province, China Development Gateway Bureau of Price & Health Department of Shanxi Province: Shanxi Province Charge Manual of Medical Service. 2005
20. Qiao YL, Franceschi S, Belinson JL, Wei LH, Xu AD, Li CQ, Niyazi M, Ren SD, Li LK, Wu RF, Huang RD, Smith JS, HPV Prevalence in Chinese women: A population-based multiple center survey in Mainland China 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China 2007
21. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, Li L, Fife D, Int J Gynecol Cancer 2003 13 819 826 10.1111/j.1525-1438.2003.13611.x 14675319
22. Different cervical cancer screening approaches in a Chinese multicentre study. Li N, Shi JF, Franceschi S, Zhang WH, Dai M, Liu B, Zhang YZ, Li LK, Wu RF, De VH, Plummer M, Qiao YL, Clifford G, Br J Cancer 2009 100 532 537 10.1038/sj.bjc.6604840 19127262